Categories
Jump to navigation
Jump to search
The following categories exist on the wiki, and may or may not be unused. Also see wanted categories.
(first | last) View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)- Multiple myeloma medications (investigational) (6 members)
- Multiple myeloma regimens (5 members)
- Muscarinic receptor antagonist (1 member)
- Mutation-specific drugs (0 members)
- Mutation-specific medications (69 members)
- Myelodysplastic syndrome medications (25 members)
- Myelodysplastic syndrome medications (investigational) (1 member)
- Myelodysplastic syndrome regimens (4 members)
- Myelofibrosis medications (11 members)
- Myelofibrosis medications (investigational) (1 member)
- Myelofibrosis regimens (2 members)
- Myeloid neoplasms (5 members)
- Myeloproliferative neoplasm medications (5 members)
- Myeloproliferative neoplasm regimens (7 members)
- Myeloproliferative neoplasms (15 members)
- NET of unknown primary regimens (1 member)
- NK- and T-cell lymphoma medications (11 members)
- NK- and T-cell lymphoma regimens (2 members)
- NK/T-cell lymphoma medications (0 members)
- NK/T-cell lymphoma regimens (0 members)
- NMPA approved drugs (17 members)
- NMPA approved in 2005 (1 member)
- NMPA approved in 2009 (1 member)
- NMPA approved in 2011 (1 member)
- NMPA approved in 2018 (5 members)
- NMPA approved in 2019 (3 members)
- NMPA approved in 2020 (1 member)
- NMPA approved in 2021 (5 members)
- NMPA approved in 2022 (2 members)
- NTRK regimens (0 members)
- Nanoparticle albumin bound chemotherapy (2 members)
- Nasal medications (3 members)
- Nasopharyngeal carcinoma medications (16 members)
- Nasopharyngeal carcinoma medications (investigational) (0 members)
- Nasopharyngeal carcinoma regimens (2 members)
- Neuroblastoma medications (23 members)
- Neuroblastoma medications (investigational) (1 member)
- Neuroblastoma regimens (3 members)
- Neuroendocrine carcinoma medications (3 members)
- Neuroendocrine carcinoma regimens (1 member)
- Neuroendocrine tumor medications (20 members)
- Neuroendocrine tumor regimens (7 members)
- Neuroendocrine tumors (1 member)
- Neurokinin 1 (NK1) antagonists (5 members)
- Neurooncology medications (6 members)
- Neurooncology regimens (9 members)
- Neutral (46 members)
- Nitrogen mustards (9 members)
- Nitrosoureas (9 members)
- Nitrosureas (0 members)